Charlie Xiang
7PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 07, 2025
Human menstrual blood-derived stem cells secreted ECM1 directly interacts with LRP1α to ameliorate hepatic fibrosis through FoxO1 and mTOR signaling pathway.Yangxin Fang, Lin Chen, Yin Yuan
|Apr 03, 2023
Human menstrual blood-derived stem cells reverse sorafenib resistance in hepatocellular carcinoma cells through the hyperactivation of mitophagy.Sining Zhou, Yiming Liu, Qi Zhang
|Feb 21, 2022
Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications.Lijun Chen, Jingjing Qu, Farhin Shaheed Kalyani
|Aug 04, 2021
Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine.Lijun Chen, Jingjing Qu, Quanhui Mei
|Feb 26, 2021
Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial.Xiaowei Xu, Wanli Jiang, Lijun Chen
|Nov 12, 2020
Human menstrual blood-derived stem cells mitigate bleomycin-induced pulmonary fibrosis through anti-apoptosis and anti-inflammatory effects.Xin Chen, Yi Wu, Yanling Wang
Pageof 2
